Manufacturer of Controlled Substances; Notice of Application, 32506 [2010-13752]

Download as PDF 32506 Federal Register / Vol. 75, No. 109 / Tuesday, June 8, 2010 / Notices Dated: May 28, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Dated: May 28, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–13738 Filed 6–7–10; 8:45 am] [FR Doc. 2010–13747 Filed 6–7–10; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Application By Notice dated October 20, 2009 and published in the Federal Register on October 28, 2009 (74 FR 55583), Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414–9321, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 12, 2010, Boehringer Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805–9372, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Schedule Drug emcdonald on DSK2BSOYB1PROD with NOTICES Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). II II The company plans to import narcotic raw materials for manufacturing and further distribution to its customers. The company is registered with DEA as a manufacturer of several controlled substances that are manufactured from raw opium, poppy straw, and concentrate of poppy straw. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Cody Laboratories, Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Cody Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. VerDate Mar<15>2010 16:31 Jun 07, 2010 Jkt 220001 Schedule Amphetamine (1100) .................... Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Methadone (9250) ........................ Methadone Intermediate (9254) ... II II II II II The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 9, 2010. Dated: May 28, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–13752 Filed 6–7–10; 8:45 am] BILLING CODE 4410–09–P PO 00000 DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated December 1, 2009, and published in the Federal Register on December 11, 2009 (74 FR 65789), Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Tetrahydrocannabinols (7370) ..... Dihydromorphine (9145) ............... Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ Schedule I I II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cedarburg Pharmaceuticals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 28, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–13751 Filed 6–7–10; 8:45 am] BILLING CODE 4410–09–P Frm 00152 Fmt 4703 Sfmt 9990 E:\FR\FM\08JNN1.SGM 08JNN1

Agencies

[Federal Register Volume 75, Number 109 (Tuesday, June 8, 2010)]
[Notices]
[Page 32506]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13752]



-----------------------------------------------------------------------



DEPARTMENT OF JUSTICE



Drug Enforcement Administration




Manufacturer of Controlled Substances; Notice of Application



    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 

Regulations (CFR), this is notice that on April 12, 2010, Boehringer 

Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 

23805-9372, made application by renewal to the Drug Enforcement 

Administration (DEA) to be registered as a bulk manufacturer of the 

basic classes of controlled substances listed in schedule II:



------------------------------------------------------------------------

                    Drug                               Schedule

------------------------------------------------------------------------

Amphetamine (1100).........................  II

Lisdexamfetamine (1205)....................  II

Methylphenidate (1724).....................  II

Methadone (9250)...........................  II

Methadone Intermediate (9254)..............  II

------------------------------------------------------------------------



    The company plans to manufacture the listed controlled substances 

in bulk for sale to its customers for formulation into finished 

pharmaceuticals.

    Any other such applicant, and any person who is presently 

registered with DEA to manufacture such substances, may file comments 

or objections to the issuance of the proposed registration pursuant to 

21 CFR 1301.33(a).

    Any such written comments or objections should be addressed, in 

quintuplicate, to the Drug Enforcement Administration, Office of 

Diversion Control, Federal Register Representative (ODL), 8701 

Morrissette Drive, Springfield, Virginia 22152; and must be filed no 

later than August 9, 2010.



     Dated: May 28, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug 

Enforcement Administration.

[FR Doc. 2010-13752 Filed 6-7-10; 8:45 am]

BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.